Cobimetinib Interactions
There are 401 drugs known to interact with cobimetinib, along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 124 are major, and 277 are moderate.
- View all 401 medications that may interact with cobimetinib
- View cobimetinib alcohol/food interactions (1)
- View cobimetinib disease interactions (7)
Most frequently checked interactions
View interaction reports for cobimetinib and the medicines listed below.
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Calcium 600+D Plus Minerals (multivitamin with minerals)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Compazine (prochlorperazine)
- Copper (copper gluconate)
- Dextrose (glucose)
- Diamox (acetazolamide)
- Diltiazem Hydrochloride SR (diltiazem)
- Emla (lidocaine / prilocaine topical)
- Ethyl Alcohol (ethanol)
- Glycerol (glycerin)
- Granix (tbo-filgrastim)
- Halaven (eribulin)
- Heparin Sodium (heparin)
- Iodides (sodium iodide)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lexapro (escitalopram)
- Lithium Carbonate ER (lithium)
- Metamucil (psyllium)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- MetroGel (metronidazole topical)
- Milk of Magnesia (magnesium hydroxide)
- MiraLAX (polyethylene glycol 3350)
- Quercetin (bioflavonoids)
- Vitamin D3 (cholecalciferol)
Cobimetinib alcohol/food interactions
There is 1 alcohol/food interaction with cobimetinib.
Cobimetinib disease interactions
There are 7 disease interactions with cobimetinib which include:
- cardiomyopathy
- hepatotoxicity
- ocular toxicities
- rhabdomyolysis
- lung toxicity
- liver dysfunction
- renal impairment
Report options
More about cobimetinib
- cobimetinib consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Dacarbazine
Dacarbazine is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Ipilimumab
ipilimumab (Yervoy) is an immunotherapy used for melanoma, renal cell carcinoma, non-small cell ...
Dabrafenib
Dabrafenib is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer, solid ...
Trametinib
Trametinib is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer, solid ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
